Overview

Targeted Ultrasound in Rheumatoid Arthritis

Status:
Completed

Trial end date:
2019-07-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine whether therapy modifications (including addition of ultrasound-guided treatment change) can change imaging results in patients with early rheumatoid arthritis in a stable clinical disease activity state.

Phase:

Phase 4

Details

Lead Sponsor:

University of Leeds

Collaborators:

AbbVie
Theorem

Treatments:

Adalimumab